Tyler Schwartz
Economics, Econometrics and Finance · Purdue University West Lafayette
Publications
14
Citations
177
Est. group size
~1
Recurring co-author estimate
Active years
7
Publishing since 2020
Tyler Schwartz's work tracks trends in pharmaceutical innovation, including annual reviews of new drug approvals by the U.S. Food and Drug Administration (FDA), as well as analysis of specific drug categories like antibiotics, monoclonal antibodies, and academic contributions to drug discovery. This research is aimed at understanding how new medicines are developed and brought to market, and where innovation is coming from within the pharmaceutical industry and academia.
Publications were absent from 2017-2019, then began a steady annual pattern from 2020 onward, averaging under two papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 2025 In Review: Trends in Pharmaceutical Innovation
Drug Discovery Today · 2026
- 2024 in Review: FDA Approval of New Medicines
Drug Discovery Today · 2025
- Target & Mechanism Selection in Pharmaceutical Innovation: A Source for Concern or Optimism?
Drug Discovery Today · 2025
- Antibiotic Development: Lessons from the Past and Future Opportunities
Pharmaceutical Research · 2024
- 2023 in review: FDA approvals of new medicines
Drug Discovery Today · 2024
- 2022 in review: FDA approvals of new medicines
Drug Discovery Today · 2023
- Monoclonal antibodies: Trends in therapeutic success and commercial focus
Drug Discovery Today · 2022
- 2021 in review: FDA approvals of new medicines
Drug Discovery Today · 2022
- Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus
Drug Discovery Today · 2022
- 2020 in review: FDA approvals of new medicines
Drug Discovery Today · 2021
- Expanding roles for academic entrepreneurship in drug discovery
Drug Discovery Today · 2020
- Sources of innovation for new medicines: questions of sustainability
Drug Discovery Today · 2020
- 2019 in review: FDA approvals of new medicines
Drug Discovery Today · 2020
- Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?
ACS Pharmacology & Translational Science · 2020
- Drug Discovery Today×12
- Pharmaceutical Research×1
- ACS Pharmacology & Translational Science×1
- Zachary Kraft
Economics, Econometrics and Finance · Purdue University West Lafayette
- George Ball
Economics, Econometrics and Finance · Indiana University
- Fran Quigley
Economics, Econometrics and Finance · Indiana University
- Claire Packer
Economics, Econometrics and Finance · The Ohio State University
- Brian O’Rourke
Economics, Econometrics and Finance · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile